Home ›
Organizations ›
CHILDHOOD ARTHRITIS & RHEUMATOLOGY RESEARCH ALLIANCE
CHILDHOOD ARTHRITIS & RHEUMATOLOGY RESEARCH ALLIANCE
DC · Disease Research · EIN 464152355
11
Executives Disclosed
$9.6M
Annual Revenue
$17.4M
Total Assets
1.9:1
Internal Pay Ratio
CHILDHOOD ARTHRITIS & RHEUMATOLOGY RESEARCH ALLIANCE has 11 executives with disclosed compensation. The highest-paid executive, Mathieu Nelessen (CEO), received peak total compensation of $377,109. The sector average for Disease Research executives is $215K.
Top Executive Compensation Over Time
Executive Compensation
| Name | Title | Peak Comp. | Latest Comp. | Years | vs. Household |
|---|---|---|---|---|---|
| Mathieu Nelessen | CEO | $377K | $377K | 2023–2024 | 5x |
| Jason Jones | sr dir of research | $201K | $201K | 2016–2016 | 2.7x |
| Yukiko Kimura | PAST PRESIDENT | $108K | $0 | 2016–2020 | 1.4x |
| Emily Von Scheven Mas | PAST PRESIDENT | $96K | $0 | 2017–2024 | 1.3x |
| Laura Schanberg | PAST PRESIDENT | $72K | $0 | 2015–2017 | 1x |
| Stacy Ardoin | PRESIDENT | $69K | $0 | 2020–2024 | 0.9x |
| Robert Fuhlbrigge | DIRECTOR | $68K | $0 | 2017–2022 | 0.9x |
| Jay Mehta | VICE PRESIDENT | $64K | $0 | 2022–2024 | 0.9x |
| Robert Colbert | PAST PRESIDENT | $50K | $0 | 2018–2024 | 0.7x |
| Yuki Kimura | Vice President | $50K | $50K | 2015–2015 | 0.7x |
| Aimee Hersh | FINANCE CHAIR | $22K | $0 | 2024–2024 | 0.3x |
Annual Summary
| Year | Executives | Avg. Comp. | Highest Comp. | Total Payroll |
|---|---|---|---|---|
| 2015 | 2 | $44K | $50K | $88K |
| 2016 | 2 | $201K | $201K | $201K |
| 2017 | 4 | $0 | $0 | $0 |
| 2018 | 4 | $0 | $0 | $0 |
| 2019 | 4 | $0 | $0 | $0 |
| 2020 | 5 | $0 | $0 | $0 |
| 2021 | 4 | $0 | $0 | $0 |
| 2022 | 5 | $0 | $0 | $0 |
| 2023 | 5 | $363K | $363K | $363K |
| 2024 | 6 | $377K | $377K | $377K |
Email Alerts
Get notified about CHILDHOOD ARTHRITIS & RHEUMATOLOGY RESEARCH ALLIANCE
Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.